Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Extrapancreatic neoplasms high with papillary mucinous neoplasms

The latest issue of Archives of Surgery finds that intraductal papillary mucinous neoplasms are frequently associated with the development of extrapancreatic neoplasms.

News image

fiogf49gjkf04

Dr Min-Gew Choi and colleagues conducted a retrospective study tertiary care referral center.

The research team reported that 61 patients underwent surgical resection for intraductal papillary mucinous neoplasms between 1993, and 2004.

The team examined 38 patients with mucinous cystic neoplasms and 50 patients with pancreatic ductal adenocarcinoma for extrapancreatic neoplasms.

The main outcome measures included the incidence and clinicopathological features of extrapancreatic neoplasms.

30% with intraductal papillary mucinous neoplasms had extrapancreatic malignancies
Archives of Surgery

The data of intraductal papillary mucinous neoplasms were compared with those with mucinous cystic neoplasm and pancreatic ductal adenocarcinoma.

The team noted that 39% of patients with intraductal papillary mucinous neoplasms developed 26 extrapancreatic neoplasms.

A further 30% with intraductal papillary mucinous neoplasms had extrapancreatic malignancies.

Gastric adenocarcinoma occurred in 33%, and colorectal adenocarcinoma in 17% were the most common neoplasms in the 24 patients.

During postoperative follow-up, 3 patients died of malignant intraductal papillary mucinous neoplasms.

Of these patients, 3 of associated malignancies, and 1 of a nonmalignancy-related cause.

There were no differences in age, sex, or family history of malignancy in patients with intraductal papillary mucinous neoplasms with and without associated malignancies.

The team also found no difference with history of cigarette smoking or alcohol abuse, or type of intraductal papillary mucinous neoplasms.

The incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms was higher than in those with other pancreatic diseases.

The researchers observed that mucinous cystic neoplasm occurred in 8% of these patients, and pancreatic ductal adenocarcinoma occurred in 10%.

Dr Choi's team concluded, “Frequently, intraductal papillary mucinous neoplasms are associated with the development of extrapancreatic neoplasms.”

“Considerable attention should be paid to the possible occurrence of other associated malignancies in patients with intraductal papillary mucinous neoplasms, either concurrently or postoperatively.”

“Further molecular studies may be necessary to elucidate the unusual association between intraductal papillary mucinous neoplasms and other primary neoplasms.”

Arch Surg 2006: 141(1): 51-6
06 February 2006

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us